Sari Lieberman

816 total citations
19 papers, 276 citations indexed

About

Sari Lieberman is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Sari Lieberman has authored 19 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Sari Lieberman's work include BRCA gene mutations in cancer (9 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic Associations and Epidemiology (2 papers). Sari Lieberman is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic Associations and Epidemiology (2 papers). Sari Lieberman collaborates with scholars based in Israel, United States and United Kingdom. Sari Lieberman's co-authors include Ephrat Levy‐Lahad, Amnon Lahad, Aviad E. Raz, Ranjit Manchanda, Faiza Gaba, Ayala Frumkin, Rachel Beeri, Tal Hadar, Rachel Rabinovitch and Tamar Ben‐Yosef and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Sari Lieberman

17 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sari Lieberman Israel 9 207 74 57 54 33 19 276
Ryan Noss United States 10 182 0.9× 88 1.2× 48 0.8× 42 0.8× 48 1.5× 17 339
Eliza Courtney Singapore 11 185 0.9× 81 1.1× 60 1.1× 65 1.2× 44 1.3× 27 319
Joyce Seldon United States 5 200 1.0× 69 0.9× 67 1.2× 45 0.8× 33 1.0× 5 256
Kelly Kohut United Kingdom 7 117 0.6× 56 0.8× 41 0.7× 59 1.1× 44 1.3× 10 200
Elana Levinson United States 6 195 0.9× 49 0.7× 47 0.8× 32 0.6× 36 1.1× 9 282
Neus Gadea Spain 9 178 0.9× 78 1.1× 29 0.5× 43 0.8× 62 1.9× 15 242
Wendy Kohlmann United States 10 185 0.9× 58 0.8× 52 0.9× 54 1.0× 54 1.6× 23 338
K Loggenberg Australia 5 208 1.0× 54 0.7× 45 0.8× 29 0.5× 37 1.1× 8 238
Erica M. Bednar United States 8 286 1.4× 43 0.6× 82 1.4× 70 1.3× 68 2.1× 17 360
S. Domchek United States 3 218 1.1× 75 1.0× 54 0.9× 56 1.0× 14 0.4× 4 267

Countries citing papers authored by Sari Lieberman

Since Specialization
Citations

This map shows the geographic impact of Sari Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari Lieberman more than expected).

Fields of papers citing papers by Sari Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sari Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari Lieberman. The network helps show where Sari Lieberman may publish in the future.

Co-authorship network of co-authors of Sari Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Sari Lieberman. A scholar is included among the top collaborators of Sari Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari Lieberman. Sari Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lieberman, Sari, Ming K. Lee, Süleyman Gülsüner, et al.. (2024). TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers. JNCI Journal of the National Cancer Institute. 117(5). 1069–1073.
2.
Lieberman, Sari, Omer Murik, Paul Renbaum, et al.. (2024). Discovering predisposing genes for hereditary breast cancer using deep learning. Briefings in Bioinformatics. 25(4).
3.
4.
Michaelson‐Cohen, Rachel, Matan J. Cohen, Dan Greenberg, et al.. (2022). Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies. Cancers. 14(24). 6113–6113. 4 indexed citations
5.
Lieberman, Sari, Rakefet Chen‐Shtoyerman, Zohar Levi, et al.. (2022). Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews. Breast Cancer Research and Treatment. 193(1). 217–224. 3 indexed citations
6.
Lieberman, Sari, et al.. (2022). Nonmalignant Features Associated with Inherited Colorectal Cancer Syndromes-Clues for Diagnosis. Cancers. 14(3). 628–628. 3 indexed citations
7.
Manchanda, Ranjit, Sari Lieberman, Faiza Gaba, Amnon Lahad, & Ephrat Levy‐Lahad. (2020). Population Screening for Inherited Predisposition to Breast and Ovarian Cancer. Annual Review of Genomics and Human Genetics. 21(1). 373–412. 28 indexed citations
8.
Hadar, Tal, et al.. (2020). Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer. JAMA Oncology. 6(9). 1460–1460. 21 indexed citations
9.
Hadar, Tal, Sari Lieberman, Esther Tahover, et al.. (2018). Impact of germline BRCA identification on subsequent breast cancer stage and therapy: Implications for routine screening.. Journal of Clinical Oncology. 36(15_suppl). 1584–1584. 1 indexed citations
10.
Lieberman, Sari, et al.. (2018). Familial communication and cascade testing among relatives of BRCA population screening participants. Genetics in Medicine. 20(11). 1446–1454. 67 indexed citations
11.
Lieberman, Sari, Tom Walsh, Tomer Adar, et al.. (2017). Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance. Gastroenterology. 152(8). 1876–1880.e1. 25 indexed citations
12.
Lieberman, Sari, et al.. (2016). Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience. Genetics in Medicine. 19(6). 628–634. 25 indexed citations
13.
Lieberman, Sari, Oded Olsha, Shalom Strano, et al.. (2016). Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral. Genetics in Medicine. 19(7). 754–762. 40 indexed citations
14.
Khateb, Samer, Mor Hanany, Avigail Beryozkin, et al.. (2016). Identification of genomic deletions causing inherited retinal degenerations by coverage analysis of whole exome sequencing data. Journal of Medical Genetics. 53(9). 600–607. 21 indexed citations
15.
Shen, O., et al.. (2014). Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21. Journal of Clinical Medicine. 3(2). 432–439. 8 indexed citations
16.
Lewis, Sharon, Ivan Macciocca, Margaret Sahhar, et al.. (2013). High school Tay–Sachs disease carrier screening: 5 to 11-year follow-up. Journal of Community Genetics. 5(2). 139–146. 9 indexed citations
17.
18.
Lieberman, Sari, et al.. (2011). Conflicts regarding genetic counseling for fragile X syndrome screening: A survey of clinical geneticists and genetic counselors in Israel. American Journal of Medical Genetics Part A. 155(9). 2154–2160. 3 indexed citations
19.
Shannon, Jackilen, et al.. (2010). Fish oil, green tea, and prostate cancer prevention.. Journal of Clinical Oncology. 28(15_suppl). TPS140–TPS140. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan Noss Breakdown of academic impact, for papers by Eliza Courtney Breakdown of academic impact, for papers by Joyce Seldon Breakdown of academic impact, for papers by Kelly Kohut Breakdown of academic impact, for papers by Elana Levinson Breakdown of academic impact, for papers by Neus Gadea Breakdown of academic impact, for papers by Wendy Kohlmann Breakdown of academic impact, for papers by K Loggenberg Breakdown of academic impact, for papers by Erica M. Bednar Breakdown of academic impact, for papers by S. Domchek
Rankless by CCL
2026